- Home
- NITO vs INBS Comparison
NITO vs INBS Comparison
Compare NITO & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NITO
- INBS
- Stock Information
- Founded
- NITO 2009
- INBS 2016
- Country
- NITO Israel
- INBS United States
- Employees
- NITO N/A
- INBS N/A
- Industry
- NITO
- INBS Medical Specialities
- Sector
- NITO
- INBS Health Care
- Exchange
- NITO NYSE
- INBS Nasdaq
- Market Cap
- NITO 7.8M
- INBS 8.7M
- IPO Year
- NITO N/A
- INBS N/A
- Fundamental
- Price
- NITO $0.24
- INBS $1.53
- Analyst Decision
- NITO
- INBS
- Analyst Count
- NITO 0
- INBS 0
- Target Price
- NITO N/A
- INBS N/A
- AVG Volume (30 Days)
- NITO 1.2M
- INBS 152.0K
- Earning Date
- NITO 08-13-2025
- INBS 05-13-2025
- Dividend Yield
- NITO N/A
- INBS N/A
- EPS Growth
- NITO N/A
- INBS N/A
- EPS
- NITO N/A
- INBS N/A
- Revenue
- NITO $232,000.00
- INBS $2,936,472.00
- Revenue This Year
- NITO N/A
- INBS $280.88
- Revenue Next Year
- NITO N/A
- INBS $126.26
- P/E Ratio
- NITO N/A
- INBS N/A
- Revenue Growth
- NITO 24.74
- INBS 3.87
- 52 Week Low
- NITO $0.16
- INBS $1.00
- 52 Week High
- NITO $3.49
- INBS $3.00
- Technical
- Relative Strength Index (RSI)
- NITO 42.39
- INBS 42.41
- Support Level
- NITO $0.23
- INBS $1.72
- Resistance Level
- NITO $0.26
- INBS $1.86
- Average True Range (ATR)
- NITO 0.02
- INBS 0.15
- MACD
- NITO -0.00
- INBS -0.04
- Stochastic Oscillator
- NITO 14.95
- INBS 1.61
About NITO N2OFF INC
N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork. The Company has two reportable segments: Pathogen prevention and prolong shelf life, and the N2O emissions Global warming solutions.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).